Skip to main content
CRNX
NASDAQ Life Sciences

Crinetics Q2 Revenue Soars on PALSONIFY Launch, But Guidance Pulled

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$83.76
Mkt Cap
$8.876B
52W Low
$25.83
52W High
$84
52W Position info
224% above low
Off High info
at 52W high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

CRNX has more than doubled off its 52-week low of $25.83.

Summary

Crinetics reported Q2 revenue driven by the U.S. launch of PALSONIFY for acromegaly, with 385 unique prescribers in the first three quarters. Net loss widened to $120.86 million, or $1.14 per share, on higher R&D spending. The company withdrew all prior guidance and will not provide updated forecasts, adding uncertainty. This follows the July 6 announcement of Vertex's $10 billion acquisition at $85 per share, which is expected to close in Q3 2026. The guidance withdrawal is notable given the pending deal, though the acquisition price remains the primary valuation anchor.

At the time of this announcement, CRNX was trading at $83.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.9B. The 52-week trading range was $25.83 to $84.00. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CRNX - Latest Insights

CRNX
Sep 01, 2026, 9:26 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $84.97
Real-time Price: $84.97 info
Change: $0 (0%) info
Market Cap: $9.01B info
CRNX
Aug 28, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $84.84
Real-time Price: $84.97 info
Change: +$0.130 (+0.15%) info
Market Cap: $9.01B info
CRNX
Aug 19, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $84.70
Real-time Price: $84.97 info
Change: +$0.270 (+0.32%) info
Market Cap: $9.01B info
CRNX
Aug 14, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $84.41
Real-time Price: $84.97 info
Change: +$0.560 (+0.66%) info
Market Cap: $9.01B info
CRNX
Aug 03, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $83.76
Real-time Price: $84.97 info
Change: +$1.21 (+1%) info
Market Cap: $9.01B info